Core Viewpoint - The article discusses the significant increase in short positions for Trump Media Technology Company following its announcement of a $6 billion all-stock merger with TAE Technologies, a fusion energy company supported by Google [1][2]. Group 1: Short Positions and Market Reactions - Short interest in Trump Media has surged by 31% since the merger announcement on December 18, reaching nearly 16 million shares, close to the highest level since October [3]. - At the closing price of $13.77 per share, these short positions represent approximately $218 million in bets against the stock [4]. - Following the merger news, Trump Media's stock price has increased by over 30%, with a notable spike of 63% in the first two trading days after the announcement, although it has since experienced some pullback [5][7]. Group 2: Stock Performance and Ownership Implications - Despite recent gains, Trump Media's stock has declined nearly 60% over the past 12 months, indicating ongoing market concerns regarding its financial performance and long-term strategy [8]. - Donald Trump holds approximately 115 million shares of Trump Media, representing about 40% of the company. Due to the dilution from the merger, his ownership stake is expected to drop to around 20% post-merger [8].

Core Viewpoint - Graycliff Exploration Limited has announced a share consolidation, reducing the number of outstanding shares to approximately 4,402,460 on a basis of one post-consolidated share for every four pre-consolidated shares [1][2][3]. Group 1: Share Consolidation Details - The consolidation ratio is set at one (1) post-consolidated common share for every four (4) pre-consolidated common shares [1][2]. - Following the consolidation, the total number of outstanding shares will be approximately 4,402,460 [1][3]. - The company's name and trading symbol will remain unchanged [1][3]. Group 2: Trading and Order Information - All open orders will be canceled at the close of business on November 28, 2025, and dealers must re-enter their orders considering the share consolidation [2][3]. - Trading on a consolidated basis is scheduled to begin on December 1, 2025 [4]. - The record date and anticipated payment date for the shares are also set for December 1, 2025 [4].

Core Viewpoint - BioVaxys Technology Corp. is consolidating its common shares at a ratio of ten pre-consolidation shares for one post-consolidation share, effective September 11, 2025 [1][2][3]. Share Consolidation Details - The company currently has 293,425,203 common shares outstanding, which will reduce to approximately 29,342,496 shares post-consolidation [3]. - No fractional shares will be issued; any fractions will be rounded up or down to the nearest whole share [3]. - The exercise price and number of shares for outstanding convertible securities will be proportionately adjusted [3]. Shareholder Actions - Registered shareholders with physical certificates must send their pre-consolidation shares along with a completed letter of transmittal to the transfer agent [4]. - Shareholders without physical certificates will automatically receive a new DRS advice for the post-consolidation shares [5]. Regulatory Approval - The consolidation was approved by the company's board of directors and is subject to the approval of the Canadian Securities Exchange (CSE) [6].